|
Re: About the Monday Presentation
|
9
|
Resverlogix Corp.
|
Nov 17, 2019 12:23AM
|
|
Re: LINK for the AGM
|
9
|
Resverlogix Corp.
|
Jun 22, 2022 03:30AM
|
|
Re: Presentation May 12th
|
9
|
Resverlogix Corp.
|
May 09, 2021 01:35PM
|
|
Re: Congratulations To.....
|
9
|
Resverlogix Corp.
|
Dec 11, 2019 09:42PM
|
|
Rough Transcript - Resverlogix Corporate Update and Conference Call - 06/10/2020
|
9
|
Resverlogix Corp.
|
Jun 11, 2020 12:57AM
|
|
Re: BOM 2 Trial
|
9
|
Resverlogix Corp.
|
Jun 11, 2020 01:15AM
|
|
Rough Transcript - RVX Confernce Call - 02/04/2021
|
9
|
Resverlogix Corp.
|
Feb 12, 2021 06:40AM
|
|
Tweet
|
9
|
Resverlogix Corp.
|
Mar 30, 2021 12:48PM
|
|
Re: Wolf - A Short Summary of Statements on Partnership Discussions since 2016
|
9
|
Resverlogix Corp.
|
Sep 20, 2020 03:21AM
|
|
August 2, 2020 Article - British Journal of Anesthesia - mentions Apabetalone & COVID
|
9
|
Resverlogix Corp.
|
Sep 10, 2020 12:49AM
|
|
Top-Line Results Webcast Transcript 09/30/2019
|
9
|
Resverlogix Corp.
|
Sep 30, 2019 11:41AM
|
|
Article - COVID-19 Lung Problems May Start in Blood Vessels
|
8
|
Resverlogix Corp.
|
Apr 27, 2020 07:39PM
|
|
Already posted?
|
8
|
Resverlogix Corp.
|
Jan 08, 2020 11:02PM
|
|
Re: Dr. Ray versus Donald McCaffrey - A huge disconnect...
|
8
|
Resverlogix Corp.
|
Nov 20, 2019 12:39AM
|
|
Re: Didn't see this one in the link library. posting just in case.
|
8
|
Resverlogix Corp.
|
Oct 05, 2018 07:04AM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
8
|
Resverlogix Corp.
|
Sep 18, 2020 07:19AM
|
|
Rough Transcript - 2021_06_22_AGM
|
8
|
Resverlogix Corp.
|
Jun 22, 2021 06:15PM
|
|
Re: Wolf - A Short Summary of Statements on Partnership Discussions since 2016 - Trying Again
|
8
|
Resverlogix Corp.
|
Sep 20, 2020 03:56AM
|
|
Zenith_AGM_2018_09_1... (rough)
|
8
|
Zenith Epigenetics
|
Sep 20, 2018 09:28AM
|
|
Re: Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript
|
8
|
Zenith Epigenetics
|
Jan 05, 2021 07:28AM
|
